AKESOgen Competitors and Similar CompaniesClear all

Akebia Therapeutics's competitors and similar companies include F-star Biotechnology.
Akebia Therapeutics
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
F-star Biotechnology
F-star Biotechnology
F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.
Founding Date
Founding Date
2007
Founding Date
2006
Type
Type
Public
Type
Private
Tags
Locations
Locations
Cambridge, US HQ
Locations
Cambridge, GB HQ
Wien, AT
Cambridge, US
Employees
Employees
324187% increase
Employees
39

Financial

Revenue (est.)
Revenue (est.)
$236.2m (FY, 2025)
Revenue (est.)
£18.7m (FY, 2018)
Net income
Net income
($5.3m) (FY, 2025)
Net income
(£2.6m) (FY, 2018)
For sources of this data, please see the company profile

View Company Profiles

F-star Biotechnology
HQ
Cambridge, GB
Employees
39

F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.

View company